180 related articles for article (PubMed ID: 31284593)
1. Novel Evidence of the Increase in Angiogenic Factor Plasma Levels after Lineage-Negative Stem/Progenitor Cell Intracoronary Infusion in Patients with Acute Myocardial Infarction.
Baumert B; Przybycień K; Paczkowska E; Kotowski M; Pius-Sadowska E; Safranow K; Peregud-Pogorzelski J; Kornacewicz-Jach Z; Peregud-Pogorzelska M; Machaliński B
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284593
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction.
Peregud-Pogorzelska M; Przybycień K; Baumert B; Kotowski M; Pius-Sadowska E; Safranow K; Peregud-Pogorzelski J; Kornacewicz-Jach Z; Paczkowska E; Machaliński B
Int J Med Sci; 2020; 17(8):985-994. PubMed ID: 32410827
[No Abstract] [Full Text] [Related]
3. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial.
Erbs S; Linke A; Schächinger V; Assmus B; Thiele H; Diederich KW; Hoffmann C; Dimmeler S; Tonn T; Hambrecht R; Zeiher AM; Schuler G
Circulation; 2007 Jul; 116(4):366-74. PubMed ID: 17620510
[TBL] [Abstract][Full Text] [Related]
4. Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.
Pawlukowska W; Baumert B; Gołąb-Janowska M; Sobuś A; Wełnicka A; Meller A; Machowska-Sempruch K; Zawiślak A; Łuczkowska K; Milczarek S; Osękowska B; Paczkowska E; Rotter I; Nowacki P; Machaliński B
Stem Cells Int; 2019; 2019():7213854. PubMed ID: 31281384
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow-derived progenitor cell transplantation for myocardial regeneration after acute infarction.
Obradović S; Rusović S; Balint B; Ristić-Andelkov A; Romanović R; Baskot B; Vojvodić D; Gligić B
Vojnosanit Pregl; 2004; 61(5):519-29. PubMed ID: 15551805
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).
Assmus B; Schächinger V; Teupe C; Britten M; Lehmann R; Döbert N; Grünwald F; Aicher A; Urbich C; Martin H; Hoelzer D; Dimmeler S; Zeiher AM
Circulation; 2002 Dec; 106(24):3009-17. PubMed ID: 12473544
[TBL] [Abstract][Full Text] [Related]
7. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
[TBL] [Abstract][Full Text] [Related]
8. Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles.
Sobuś A; Baumert B; Litwińska Z; Gołąb-Janowska M; Stępniewski J; Kotowski M; Pius-Sadowska E; Kawa MP; Gródecka-Szwajkiewicz D; Peregud-Pogorzelski J; Dulak J; Nowacki P; Machaliński B
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702606
[TBL] [Abstract][Full Text] [Related]
9. Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial.
Schächinger V; Assmus B; Honold J; Lehmann R; Hofmann WK; Martin H; Dimmeler S; Zeiher AM
Clin Res Cardiol; 2006 Jan; 95(1):13-22. PubMed ID: 16598441
[TBL] [Abstract][Full Text] [Related]
10. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
Britten MB; Abolmaali ND; Assmus B; Lehmann R; Honold J; Schmitt J; Vogl TJ; Martin H; Schächinger V; Dimmeler S; Zeiher AM
Circulation; 2003 Nov; 108(18):2212-8. PubMed ID: 14557356
[TBL] [Abstract][Full Text] [Related]
11. Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials.
Forest VF; Tirouvanziam AM; Perigaud C; Fernandes S; Fusellier MS; Desfontis JC; Toquet CS; Heymann MF; Crochet DP; Lemarchand PF
Stem Cell Res Ther; 2010 Mar; 1(1):4. PubMed ID: 20504285
[TBL] [Abstract][Full Text] [Related]
12. Articulation recovery in ALS patients after lineage-negative adjuvant cell therapy - preliminary report.
Pawlukowska W; Baumert B; Gołąb-Janowska M; Pius-Sadowska E; Litwińska Z; Kotowski M; Meller A; Rotter I; Peregud-Pogorzelski J; Nowacki P
Int J Med Sci; 2020; 17(13):1927-1935. PubMed ID: 32788871
[No Abstract] [Full Text] [Related]
13. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction.
Assmus B; Rolf A; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Tillmanns H; Yu J; Corti R; Mathey DG; Hamm CW; Süselbeck T; Tonn T; Dimmeler S; Dill T; Zeiher AM; Schächinger V;
Circ Heart Fail; 2010 Jan; 3(1):89-96. PubMed ID: 19996415
[TBL] [Abstract][Full Text] [Related]
14. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease.
Yokoyama S; Fukuda N; Li Y; Hagikura K; Takayama T; Kunimoto S; Honye J; Saito S; Wada M; Satomi A; Kato M; Mugishima H; Kusumi Y; Mitsumata M; Murohara T
J Mol Cell Cardiol; 2006 Jan; 40(1):24-34. PubMed ID: 16271723
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Hölschermann H; Yu J; Corti R; Mathey DG; Hamm CW; Süselbeck T; Assmus B; Tonn T; Dimmeler S; Zeiher AM;
N Engl J Med; 2006 Sep; 355(12):1210-21. PubMed ID: 16990384
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction.
Shyu KG; Wang BW; Hung HF; Chang CC; Shih DT
J Biomed Sci; 2006 Jan; 13(1):47-58. PubMed ID: 16283432
[TBL] [Abstract][Full Text] [Related]
18. The long-term effect of autologous endothelial progenitor cells from peripheral blood implantation on infarcted myocardial contractile force.
Lian F; Xue S; Gu P; Zhu HS
J Int Med Res; 2008; 36(1):40-6. PubMed ID: 18230266
[TBL] [Abstract][Full Text] [Related]
19. Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection.
Njerve IU; Solheim S; Lunde K; Hoffmann P; Arnesen H; Seljeflot I
Cytokine; 2014 Sep; 69(1):131-5. PubMed ID: 24930044
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
